Phosphoproteomic signatures for early detection and stratification of AML

Scott Davis

Exposures from Chernobyl

Leukaemia

Pediatric oncology or childhood cancer Radiation Oncology

Carl E Allen

Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment

Leukaemia

Jeffrey S Miller

NK Cells, their Receptors and Unrelated Donor Transplant

Leukaemia

Hematology and hematologic malignancies Pathology

Tak Mak

CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Leukaemia Brain, nervous system

Global Noncommunicable Diseases Intiatives

Implementation of an immunophenotyping laboratory at the Haematooncology Unit of the Chair and Pediatrics Service of the Medical Science

Leukaemia

Soheil Meshinchi

Biology and Prognostic Implications of FLT3 Mutations in AML

Leukaemia

Pier Paolo Pandolfi

Targeting Tumor Suppressive Pathways for Cancer Therapy

Leukaemia

Investigator from University of Helsinki

Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells

Leukaemia

Paola Friedrich-Medina

Pediatric Oncology Twinning Program

Sarcoma Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Pediatric oncology or childhood cancer